Application value of cerebrospinal fluid MRLCs combined with lactate dehydrogenase detection in diagnosis of central nervous system leukemia
10.3969/j.issn.1673-4130.2017.16.006
- VernacularTitle:脑脊液MRD联合乳酸脱氢酶检测在中枢神经系统白血病诊断中的应用价值
- Author:
Chang TAN
;
Feng LI
;
Zeyan PU
;
Yanli LIANG
;
Lujie FENG
- Keywords:
ieukemia;
minimal residual disease;
iactate dehydrogenase;
cerebrospinal fluid
- From:
International Journal of Laboratory Medicine
2017;38(16):2190-2192
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the apllication value of cerebraspinal fluid minimal residual leukemia cells(MRLCs) combined with lactate dehydrogenase(LDH) detection in early diagnosis of central nervous system leukemia(CNSL) to provide a laboratory basis for clinical diagnosis and evaluation of disease progression and therapeutic effect.Methods Thirty inpatiernts without blood disease and central nervous system(CNS) organic diseases,and normal CSF routine and detected biochemical indexes were selected as the control group and 96 cases of acute leukemia (AL) diagnosed by bone marrow puncture FAB morphology and flow cytometry typing served as the disease group.Flow cytometry was used to detect the MRLCs in CSF,the activity of LDH in CSF was detected by the rate method,and the detection results were performed the comparative analysis.Results Among 96 cases of AL,30 patients with CNSL had 13 cases of positive MRLCs in CSF,the positive rate was 43.33%,among 66 cases of non-MRLCs,MRLCs was not detected detected.Among 96 cases of AL,CSF LDH level in 30 cases of CNSL was (30.54±10.29)U/L,which was significantly higher (16.16±7.12)U/L in the patients without CNSL,the difference between the two groups was statistically significant (P<0.05).Conclusion The detection of MRLCs and LDH in CSF of AL can be used as a laboratory diagnostic index for early diagnosis of CNSL,and MRLCs combined with LDH detection can improve the positive diagnosis rate of CNSL.
